New functions for the matrix metalloproteinases in cancer progressionMikala Egeblad(University of California, San Francisco), Zena Werb(University of California, San Francisco)Nature reviews. CancerMarch 1, 200210.1038/nrc745Cited by 6,052SaveCiteExport RISWatch citationsAbstractRelated PapersMatrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesisGabriele Bergers, Rolf A. Brekken, Gerald McMahon et al.|Nature Cell Biology|2000|2.8kTGF-β signaling in tumor suppression and cancer progressionRik Derynck, Rosemary J. Akhurst, Allan Balmain|Nature Genetics|2001|2.3kReduced angiogenesis and tumor progression in gelatinase A-deficient mice.Takeshi Itoh, Masatoshi Tanioka, Hiroki Yoshida et al.|PubMed|1998|878Tumor targeting with a selective gelatinase inhibitorErkki Koivunen, Wadih Arap, Heli Valtanen et al.|Nature Biotechnology|1999|580Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity.Nicholas Mitsiades, Wei‐Hsuan Yu, V. Poulaki et al.|PubMed|2001|371